METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer
Anwar R. Padhani(Mount Vernon Hospital), Johann S. de Bono(Royal Marsden NHS Foundation Trust)
Cited by 326
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
|New England Journal of Medicine|2020|760
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
|CA A Cancer Journal for Clinicians|2011|209
Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial
|Cancer Discovery|2021|160
The molecular underpinnings of prostate cancer: impacts on management and pathology practice
|The Journal of Pathology|2016|43